AzTrials
AzTrials

Dietary SupplementationNCT05116150

Effects of Combined Grape Seed Extract and L-citrulline Supplementation on Hemodynamic Responses in Young Males

A study testing Grape seed extract in people with Dietary Supplementation, run by California Baptist University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study was to examine the additive benefits with combined grape seed extract (GSE) and L-citrulline supplementation on hemodynamic responses to dynamic exercise, 11 young, healthy males were recruited for this study. Read more about this study

Who is it for?
Ages 18 to 30 years, men onlyHealthy volunteers can take part
Conditions the study is for
Dietary Supplementation
What is being tested?
Grape seed extract
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
11 participants
Where
1 siteUnited States
Study dates
1 Jun 2019to 1 Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • healthy males

Who cannot join

  • cardiovascular and/or pulmonary disease, musculoskeletal disorders, or medications that prevent the safe completion of the exercise protocol

Trial locations and contacts

1 site in 1 country.

United States1 site
  • California Baptist University

    Riverside, California, 92504

Other trials in United States

About this study

This study was to examine the additive benefits with combined grape seed extract (GSE) and L-citrulline supplementation on hemodynamic responses to dynamic exercise, 11 young, healthy males were recruited for this study.

Read the detailed description

The investigators aimed the additive effects of combined grape seed extract (GSE) and L-citrulline supplementation on hemodynamic responses to dynamic exercise, 11 young, healthy males were recruited for this study. Effects of 7 days of combined GSE with L-citrulline supplementation on systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure (MAP), cardiac output (CO), total vascular conductance (TVC), and oxygen consumption (O2) were examined at rest and during cycling exercise.

Being tested
Grape seed extract, Placebo

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Grape seed extractDietary supplement

    Effects of 7 days of combined GSE with L-citrulline supplementation on hemodynamic responses at rest and during cycling exercise.

  • PlaceboDietary supplement

    Effects of 7 days of placebo supplementation on hemodynamic responses at rest and during cycling exercise.

Study groups in NCT05116150
Study groupRoleWhat they receive
Randomized double blind grape seed extract designActive comparatorGrape see extract
Receives: Dietary Supplement: Grape seed extract; Dietary Supplement: Placebo
Randomized double blind placebo designPlacebo comparatorPlacebo
Receives: Dietary Supplement: Grape seed extract; Dietary Supplement: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Systolic blood pressure (mmHg)

    by sphygmomanometer

    Measured: 7 days

  2. Diastolic blood pressure (mmHg)

    by sphygmomanometer

    Measured: 7 days

  3. Mean arterial pressure (mmHg)

    calculated (MAP = (SBP-DBP)/3 + DBP

    Measured: 7 days

  4. Heart rate (bpm)

    measured using Physio Flow (non-invasive device)

    Measured: 7 days

  5. Stroke volume (ml)

    measured using Physio Flow (non-invasive device)

    Measured: 7 days

  6. Cardiac output (l/min)

    calculated: HR (bpm) x SV (ml)

    Measured: 7 days

  7. Total vascular conductance (ml/min/mmHg)

    calculated: CO (ml/min) / MAP (mmHg)

    Measured: 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Nov 2021
  2. Study start1 Jun 2019
  3. Primary completion1 Dec 2019
  4. Study completion1 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
11 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05116150
Sponsor's protocol ID
112-1819 EXP
Status last verified
Nov 2021
First submitted
19 Oct 2021
Last updated
10 Nov 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Grape seed extract in people with Dietary Supplementation, run by California Baptist University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Systolic blood pressure (mmHg) (time frame: 7 days). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in